Several studies have shown that supervised PA is advantageous; in patients with T2D on key metabolic factors (6-9) and that it improves quality of life and reduces the risk of all-cause mortality (1,2,6,10,11,12). Due to the many beneficial effects of PA on T2D patients, PA is an important factor in the prevention and treatment of T2D (13). Long-term PA interventions have employed supervised exercise regimes (14,15) that are effective, but also demanding and expensive. Attempts to increase the daily physical activity level on a large scale, in a free-living "real life", have very little effect (14-16) despite well-established patient education programs. In general, the exercise adherence is low and dropout rates are high in this group of patients. A large number of patients with T2D experience diminished quality of life, decreased physical functioning, diminished exercise tolerance (17), numerous patients are unmotivated or incapable to change behaviour and the prevalence of depressive and anxiety symptoms are highly prevalent in T2D patients (17,18,19). Collectively this could pose important barriers to engagement in exercise and reaching the recommended level of PA (20).